Issue link: https://viewer.e-digitaledition.com/i/699354
Dr. Zalasin and Vanessa Tannheimer, RDMS, ultrasonographer, review a study with a patient. Hologic Selenia Dimensions helps find cancers earlier and reduce callbacks. Hologic's 3D MAMMOGRAPHY technology is becoming the new standard of care in leading breast centers around the world. In Defense of Dense Breasts BRE A ST S A RE COMPOSED of a combination of glandular tissue, ducts, fibrous tissue and fat. Breasts with a higher- than-average amount of fibrous and glandular tissue in comparison with the amount of fat are considered dense. "I take care to explain to patients that there is noth- ing wrong with dense breast tissue," says Stefanie Zalasin, MD. "It's simply a genetic trait, similar to having brown hair instead of blond or blue eyes instead of brown. However, dense breasts can make screening for breast cancer more difficult." Breast tissue can vary in density. The size and shape of breasts do not matter — density can affect any type of breast, and imaging is the only way to determine whether a patient has dense breasts. Fibrous and glandular tissues appear white on a mammogram, as do certain types of tumors. Telling them apart on the resulting images is a complicated task even for the most experienced breast imagers. In 2013, New York state began requiring physicians to send letters to patients whose breasts are identified as dense during a mammogram. Today, 27 states have such laws, and several others have legislation in the works to mandate this type of alert. At Yorktown Imaging, Dr. Zalasin has a one-on-one discussion with each patient found to have dense breasts and ensures patients under - stand the findings, as well as why supplemental imaging could be necessary to screen for abnormalities. "These consultations get more accurate information in women's hands," Dr. Zalasin says. "It is important to reassure women that being told you have dense breasts does not mean you have cancer. It's simply a factor that may indicate the need to take a closer look with another modality, such as breast MRI, to identify abnormalities we might wish to investigate further." to be active participants in their health care. This deep level of provider-patient interaction is nowhere more evident than in the one-on-one consultations Dr. Zalasin has with patients to discuss the results of their exams — consultations that can have a profound impact on patient outcomes. This framework of partnership was apparent in the case of a woman who had a normal screening mammogram and was found to have dense breasts. "Immediately after the exam, I met with her and we discussed why supplemental screening was important, given that she had dense breasts and a strong family history of breast cancer," Dr. Zalasin says. "Having this conversation allowed me the opportunity to explain her risk factors, understand her concerns and answer her questions. She scheduled a breast MRI, which revealed an abnormal finding. I performed an MRI-guided biopsy, and that led to the diagnosis of an early-stage breast cancer. Because of the depth and breadth of our imaging capabilities, the patient was able to have all of her exams conducted conveniently at Yorktown Imaging, and she is doing well." In another instance, Dr. Zalasin was able to expedite testing for a woman whose screening mammogram revealed calcifications in the breast tissue. "I discussed her mammography results with her on the same day, explained in detail how we conduct a biopsy and helped her schedule the procedure. I also consulted with her referring physician, sharing what we had found and my recommendations," Dr. Zalasin says. RIGOROUS COLLABORATION Throughout the screening, diagnosis and treatment process, Dr. Zalasin and her colleagues place a high priority on close col- laboration with the primary care physicians, nurse practitioners and other providers who refer patients to Yorktown Imaging. They a lso partner with cancer navigators from Northern Westchester Hospital, who help coordinate treatment and test- ing and provide educational resources and a stable, reassuring presence for individuals diagnosed with cancer. M D N E W S .C O M /// M D N E W S L O W E R H U D S O N / B R O N X ■ 2 016 0 9

